NO883554L - Fremgangsmaate til isolering av basiske proteiner fra proteinblandinger som inneholder slike basiske proteiner. - Google Patents

Fremgangsmaate til isolering av basiske proteiner fra proteinblandinger som inneholder slike basiske proteiner.

Info

Publication number
NO883554L
NO883554L NO88883554A NO883554A NO883554L NO 883554 L NO883554 L NO 883554L NO 88883554 A NO88883554 A NO 88883554A NO 883554 A NO883554 A NO 883554A NO 883554 L NO883554 L NO 883554L
Authority
NO
Norway
Prior art keywords
basic proteins
isolation
procedure
ingredients containing
protein ingredients
Prior art date
Application number
NO88883554A
Other languages
English (en)
Other versions
NO175004B (no
NO883554D0 (no
NO175004C (no
Inventor
Michael Doerschug
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO883554D0 publication Critical patent/NO883554D0/no
Publication of NO883554L publication Critical patent/NO883554L/no
Publication of NO175004B publication Critical patent/NO175004B/no
Publication of NO175004C publication Critical patent/NO175004C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO883554A 1987-08-11 1988-08-10 Fremgangsmåte til isolering av basiske insuliner fra proteinblandinger som inneholder slike basiske insuliner NO175004C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873726655 DE3726655A1 (de) 1987-08-11 1987-08-11 Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten

Publications (4)

Publication Number Publication Date
NO883554D0 NO883554D0 (no) 1988-08-10
NO883554L true NO883554L (no) 1989-02-13
NO175004B NO175004B (no) 1994-05-09
NO175004C NO175004C (no) 1994-08-17

Family

ID=6333496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883554A NO175004C (no) 1987-08-11 1988-08-10 Fremgangsmåte til isolering av basiske insuliner fra proteinblandinger som inneholder slike basiske insuliner

Country Status (19)

Country Link
US (1) US5101013A (no)
EP (1) EP0305760B1 (no)
JP (1) JP2587867B2 (no)
KR (1) KR0129539B1 (no)
AT (1) ATE96447T1 (no)
AU (1) AU609170B2 (no)
CA (1) CA1340237C (no)
DE (2) DE3726655A1 (no)
DK (1) DK173502B1 (no)
ES (1) ES2047007T3 (no)
FI (1) FI91875C (no)
HU (1) HU198218B (no)
IE (1) IE61557B1 (no)
IL (1) IL87385A (no)
NO (1) NO175004C (no)
NZ (1) NZ225746A (no)
PH (1) PH26874A (no)
PT (1) PT88230B (no)
ZA (1) ZA885871B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
DK0821006T3 (da) 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19652713C2 (de) * 1996-12-18 2001-11-22 Aventis Pharma Gmbh Verfahren zur Reinigung von Insulin und Insulinderivaten durch Chromatographie an stark saurem Kationenaustauscher
KR100341297B1 (ko) * 1997-03-29 2002-11-16 주식회사종근당 재조합활성형프로인슐린의분리.정제방법
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
US6444788B1 (en) 1999-03-15 2002-09-03 Novo Nordisk A/S Ion exchange chromatography of GLP-1, analogs and derivatives thereof
WO2000055203A1 (en) * 1999-03-15 2000-09-21 Novo Nordisk A/S Ion exchange chromatographic separation of glp-1 and related peptides
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
SE0300791D0 (sv) * 2003-03-20 2003-03-20 Amersham Biosciences Ab Use of ph-responsive polymers
KR20060106812A (ko) * 2003-08-21 2006-10-12 노보 노르디스크 에이/에스 라세미화 아미노산을 포함하는 폴리펩티드의 분리
EP1958879B1 (en) * 2005-08-04 2012-07-11 Toyo Seikan Kaisha, Ltd. Method for sterilization of plastic bottle
DK2349324T3 (en) 2008-10-17 2017-12-11 Sanofi Aventis Deutschland COMBINATION OF AN INSULIN AND A GLP-1 AGONIST
FR2947818B1 (fr) * 2009-07-09 2011-07-29 Inst Superieur Des Sciences Agronomiques Agroalimentaires Horticoles Et Du Paysage Agro Campus Ouest Utilisation d'un coproduit issu d'un procede d'extraction du lysozyme a partir de blanc d'oeuf, pour l'obtention d'au moins une proteine basique de blanc d'oeuf
KR101836070B1 (ko) 2009-11-13 2018-03-09 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ－１ 작용제, 인슐린 및 메티오닌을 포함하는 약제학적 조성물
JP5973918B2 (ja) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｇｌｐ−１アゴニスト及びメチオニンを含む薬学的組成物
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN108079281A (zh) 2011-08-29 2018-05-29 赛诺菲-安万特德国有限公司 用于2型糖尿病患者中的血糖控制的药物组合
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
EP2748181B1 (en) 2011-09-30 2016-03-30 GE Healthcare BioProcess R&D AB Method for purification of cleaved pro-insulin
US10421795B2 (en) * 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
EP3116531B1 (en) 2014-03-14 2021-10-20 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2018147393A1 (ja) * 2017-02-10 2018-08-16 三菱ケミカル株式会社 ヒトインスリン精製用分離剤及びヒトインスリンの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2629568C3 (de) * 1976-07-01 1981-09-10 Hoechst Ag, 6000 Frankfurt Verfahren zur Reinigung von Insulin, seinen Analogen und Derivaten
NL7713966A (nl) * 1976-12-27 1978-06-29 Univ Minnesota Werkwijze voor het behandelen van insuline.
DK311477A (da) * 1977-07-08 1979-01-09 Leo Lab Fremgangsmaade ved fremstilling af rent insulin
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
DD247684A1 (de) * 1983-04-14 1987-07-15 Ulrich Krabiell Verfahren zur isolierung von insulinderivaten
ATE95236T1 (de) * 1983-04-25 1993-10-15 Chiron Corp Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren.
DE3440988A1 (de) * 1984-11-09 1986-07-10 Hoechst Ag, 6230 Frankfurt Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung
DE3511269A1 (de) * 1985-04-12 1986-10-09 Veb Berlin-Chemie, Ddr 1199 Berlin Verfahren zur reinigung von insulin
JPS6379591A (ja) * 1986-09-22 1988-04-09 Mitsui Toatsu Chem Inc ｔＰＡの精製方法
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0365858B1 (en) * 1988-10-26 1994-11-30 American Cyanamid Company Process for reducing the aggregate content of growth hormone-like materials

Also Published As

Publication number Publication date
FI91875B (fi) 1994-05-13
IE882441L (en) 1989-02-11
DK447688D0 (da) 1988-08-10
HU198218B (en) 1989-08-28
NZ225746A (en) 1990-11-27
NO175004B (no) 1994-05-09
DK173502B1 (da) 2001-01-08
FI883708A0 (fi) 1988-08-09
ZA885871B (en) 1989-04-26
AU609170B2 (en) 1991-04-26
DK447688A (da) 1989-02-12
IL87385A (en) 1993-08-18
JP2587867B2 (ja) 1997-03-05
FI91875C (fi) 1994-08-25
PH26874A (en) 1992-11-16
ES2047007T3 (es) 1994-02-16
IE61557B1 (en) 1994-11-16
FI883708A (fi) 1989-02-12
EP0305760A2 (de) 1989-03-08
JPS6486896A (en) 1989-03-31
HUT47958A (en) 1989-04-28
EP0305760B1 (de) 1993-10-27
CA1340237C (en) 1998-12-15
PT88230A (pt) 1989-06-30
ATE96447T1 (de) 1993-11-15
AU2059188A (en) 1989-02-16
DE3726655A1 (de) 1989-02-23
KR0129539B1 (ko) 1998-04-04
NO883554D0 (no) 1988-08-10
PT88230B (pt) 1995-03-01
DE3885214D1 (de) 1993-12-02
EP0305760A3 (en) 1990-06-06
NO175004C (no) 1994-08-17
KR890003799A (ko) 1989-04-18
US5101013A (en) 1992-03-31
IL87385A0 (en) 1989-01-31

Similar Documents

Publication Publication Date Title
NO883554D0 (no) Fremgangsmaate til isolering av basiske proteiner fra proteinblandinger som inneholder slike basiske proteiner.
NO830110L (no) 6-substituert-s-triazolo(3,4-a)ftalazinderivater og fremgangsmaate for deres fremstilling
NO883073L (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate for fremstilling av dem, farmasoeytiske preparater paa basis av disse forbindelsene, deres anvendelse saavel som mellomprodukter.
NO823674L (no) Derivater av cis, endo-2-azabicyklo-(3.3.0)-oktan-3-3-karboksylsyrer, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse
DK346783A (da) Triphenylimidazolyloxyalkansyrer og derivater deraf, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
LV10490A (lv) DNS seciba kas kode proteinus ar HUSI-tipa inhibitoru biologisko aktivitati mineto proteinu iegusanas biotehnologiskais panemiens farmaceitiskas kompozicijas kas satur minetos proteinus
DK383388D0 (da) 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
IE822519L (en) Phosphonic acid derivatives
Grimbleby et al. Binding of trichloroacetic acid by protein
DK319384A (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
NO881111L (no) Fremgangsmaate til isolering av basalmembranproteiner fra menneskelige og dyriske vev.
NO167813C (no) Fremgangsmaate for fremstilling av carboxylgruppeholdige polyamider, og anvendelse av disse som lakkbindemiddel.
DK438883D0 (da) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinoliner, samt fremgangsmade til fremstilling heraf
ES555393A0 (es) Procedimiento para preparar compuestos dimeros de derivados de aminoacidos.
DK348388A (da) Sulfonylurinstofforbindelser, fremgangsmaade til deres fremstilling, samt deres anvendelser som ukrudtsbekaempelsesmidler
IL65377A (en) Substituted methylphosphonic acid derivatives,their preparation and herbicidal compositions containing them
DK147384D0 (da) 7,8,9,10-tetrahydrothieno(3,2-e)pyrido(4,3-b)indoler,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
ES531495A0 (es) Procedimiento para preparar un hidrolizado proteinico
NO820618L (no) 7-acylamido-3-cefem-4-karboksylsyreforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse forbindelser og anvendelse av sistnevnte
Cho et al. Isolation of Sunflower Seed Protein and its Chemical Composition
Kristoffersen et al. Identification of 20β-Hydroxy-pregn-4-ene-3-one in Luteal Tissue from Pregnant Whales
NO831594L (no) Derivater av cis, endo-2-azabiscyklo-(3.3.0)-oktan-3-karboksylsyre, fremgangsmaate til deres fremstilling, midler som inneholder disse samt deres anvendelse
NO831593L (no) Derivater av cis, endo-2-azabiscyklo-(3.3.0)-oktan-3-karboksylsyre, fremgangsmaate til deres fremstilling, midler som inneholder disse samt deres anvendelse
ES545496A0 (es) Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos
DK164317C (da) Quinoxalin-2,3-dion-forbindelser, fremgangsmaade til deres fremstilling og farmaceutiske praeparater hvori forbindelserne indgaar

Legal Events

Date Code Title Description
MK1K Patent expired